A detailed history of Victory Capital Management Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 284,444 shares of MRNA stock, worth $11.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
284,444
Previous 284,337 0.04%
Holding current value
$11.3 Million
Previous $33.8 Million 43.7%
% of portfolio
0.02%
Previous 0.04%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$63.64 - $125.14 $6,809 - $13,389
107 Added 0.04%
284,444 $19 Million
Q2 2024

Aug 05, 2024

SELL
$101.21 - $166.61 $1.54 Million - $2.53 Million
-15,173 Reduced 5.07%
284,337 $33.8 Million
Q1 2024

May 03, 2024

SELL
$85.37 - $115.44 $309,210 - $418,123
-3,622 Reduced 1.19%
299,510 $31.9 Million
Q4 2023

Feb 05, 2024

BUY
$69.51 - $104.43 $1.47 Million - $2.21 Million
21,135 Added 7.49%
303,132 $30.1 Million
Q3 2023

Nov 06, 2023

BUY
$96.41 - $126.61 $3.12 Million - $4.1 Million
32,371 Added 12.97%
281,997 $29.1 Million
Q2 2023

Jul 27, 2023

SELL
$118.5 - $160.53 $4.14 Million - $5.61 Million
-34,960 Reduced 12.28%
249,626 $30.3 Million
Q1 2023

May 02, 2023

SELL
$135.66 - $197.02 $24.9 Million - $36.2 Million
-183,747 Reduced 39.23%
284,586 $43.7 Million
Q4 2022

Feb 10, 2023

BUY
$118.38 - $210.04 $806,049 - $1.43 Million
6,809 Added 1.48%
468,333 $84.1 Million
Q4 2022

Feb 09, 2023

BUY
$118.38 - $210.04 $20.2 Million - $35.8 Million
170,238 Added 58.44%
461,524 $82.9 Million
Q3 2022

Nov 02, 2022

BUY
$118.07 - $194.18 $3.17 Million - $5.21 Million
26,838 Added 10.15%
291,286 $34.4 Million
Q2 2022

Aug 01, 2022

SELL
$117.13 - $176.59 $1.32 Million - $1.99 Million
-11,285 Reduced 4.09%
264,448 $37.8 Million
Q1 2022

May 04, 2022

BUY
$126.46 - $235.05 $2.44 Million - $4.54 Million
19,330 Added 7.54%
275,733 $37.1 Million
Q4 2021

Feb 07, 2022

BUY
$225.82 - $368.51 $4.91 Million - $8.01 Million
21,738 Added 9.26%
256,403 $65.1 Million
Q3 2021

Nov 02, 2021

SELL
$221.9 - $484.47 $12.1 Million - $26.3 Million
-54,370 Reduced 18.81%
234,665 $90.3 Million
Q2 2021

Aug 03, 2021

SELL
$129.91 - $234.98 $866,759 - $1.57 Million
-6,672 Reduced 2.26%
289,035 $67.9 Million
Q1 2021

May 04, 2021

SELL
$109.18 - $185.98 $2.25 Million - $3.83 Million
-20,601 Reduced 6.51%
295,707 $38.7 Million
Q4 2020

Feb 01, 2021

BUY
$65.74 - $169.86 $3.05 Million - $7.88 Million
46,409 Added 17.19%
316,308 $33 Million
Q3 2020

Nov 09, 2020

BUY
$54.34 - $94.85 $12.1 Million - $21.1 Million
222,174 Added 465.53%
269,899 $19.1 Million
Q2 2020

Aug 07, 2020

BUY
$29.67 - $80.0 $299,993 - $808,880
10,111 Added 26.88%
47,725 $3.06 Million
Q1 2020

May 04, 2020

SELL
$17.78 - $31.58 $65,625 - $116,561
-3,691 Reduced 8.94%
37,614 $1.13 Million
Q4 2019

Feb 06, 2020

BUY
$13.93 - $21.28 $24,266 - $37,069
1,742 Added 4.4%
41,305 $808,000
Q4 2019

Feb 04, 2020

BUY
$13.93 - $21.28 $121,985 - $186,348
8,757 Added 28.43%
39,563 $811,000
Q3 2019

Nov 12, 2019

BUY
$12.26 - $18.07 $377,681 - $556,664
30,806 New
30,806 $490,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.